Susquehanna Fundamental Investments, LLC Becton Dickinson & CO Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $11.2 Million - $13.2 Million	51,433 Added 497.8%	61,765 $15.7 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $48,529 - $251,282	951 Added 10.14%	10,332 $2.3 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $5.37 Million - $5.96 Million	-22,043 Reduced 70.15%	9,381 $2.5 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $21.1 Million - $23 Million	-91,537 Reduced 74.44%	31,424 $7.9 Million
Q2 2021 Aug 11, 2021	BUY	$232.65 - $254.58 $3.28 Million - $3.59 Million	14,100 Added 12.95%	122,961 $29.9 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $15.1 Million - $16.7 Million	65,151 Added 149.05%	108,861 $26.5 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $9.7 Million - $10.8 Million	43,710 New	43,710 $10.9 Million

1,739

248M

687K

788K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.